Title:
NOVEL PYRIDONE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2003/078422
Kind Code:
A1
Abstract:
A compound represented by the general formula (I): (I) (wherein R1 means hydrogen, halogeno, cyano, lower alkyl, lower haloalkyl, hydroxy, lower alkoxy, or aralkyloxy; R2 and R3 each independently means hydrogen, halogeno, or lower haloalkyl; and R4 and R5 each independently means hydrogen or halogeno) and the like. The compounds are useful as a therapeutic agent for various diseases in which NPY participates, e.g., overeating, obesity, and diabetes.
Inventors:
SATO NAGAAKI (JP)
NAGASE TSUYOSHI (JP)
NAGAI KEITA (JP)
ANDO MAKOTO (JP)
KANATANI AKIO (JP)
NAGASE TSUYOSHI (JP)
NAGAI KEITA (JP)
ANDO MAKOTO (JP)
KANATANI AKIO (JP)
Application Number:
PCT/JP2003/003115
Publication Date:
September 25, 2003
Filing Date:
March 14, 2003
Export Citation:
Assignee:
BANYU PHARMA CO LTD (JP)
SATO NAGAAKI (JP)
NAGASE TSUYOSHI (JP)
NAGAI KEITA (JP)
ANDO MAKOTO (JP)
KANATANI AKIO (JP)
SATO NAGAAKI (JP)
NAGASE TSUYOSHI (JP)
NAGAI KEITA (JP)
ANDO MAKOTO (JP)
KANATANI AKIO (JP)
International Classes:
A61K31/444; A61P1/00; A61P3/04; A61P3/10; A61P9/00; A61P9/12; A61P11/00; A61P13/12; A61P15/00; A61P25/00; A61P25/04; A61P25/08; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P27/06; A61P29/00; A61P43/00; C07D401/14; (IPC1-7): C07D401/14; A61K31/444; A61P1/00; A61P3/04; A61P3/10; A61P9/00; A61P9/12; A61P11/00; A61P13/12; A61P15/00; A61P25/00; A61P25/04; A61P25/08; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/32; A61P27/06; A61P29/00; A61P43/00
Domestic Patent References:
WO2001062738A1 | 2001-08-30 | |||
WO1988004938A1 | 1988-07-14 |
Other References:
See also references of EP 1486497A4
Attorney, Agent or Firm:
BANYU PHARMACEUTICAL CO., LTD. (Chuo-ku, Tokyo, JP)
Download PDF:
Previous Patent: PROCESS FOR MAKING CHIRAL 1,4-DISUBSTITUTED PIPERAZINES
Next Patent: AZOLYLAMINOAZINE AS INHIBITORS OF PROTEIN KINASES
Next Patent: AZOLYLAMINOAZINE AS INHIBITORS OF PROTEIN KINASES